| Literature DB >> 29651691 |
Elvis Tajoache Amin1,2,3, Charles Njumkeng4,5,6, Belmond T Kika6,7,8, Akemfua Fualefac9, Patrick Njukeng9.
Abstract
INTRODUCTION: Antimicrobial resistance has become a global concern and is particularly affecting developing countries where infectious diseases and poverty are endemic. The effectiveness of currently available antimicrobials is decreasing as a result of increasing resistant strains among clinical isolates.Entities:
Year: 2018 PMID: 29651691 PMCID: PMC5984608 DOI: 10.1007/s40801-018-0132-2
Source DB: PubMed Journal: Drugs Real World Outcomes ISSN: 2198-9788
Distribution of study participants from various laboratories according to sex, age, specimen and isolates
| Variable | Frequency |
|---|---|
| Sex | |
| Female | 243 (57.3) |
| Male | 180 (42.7) |
| Age group in years | |
| < 20 | 36 (8.5) |
| 20–39 | 271 (63.9) |
| 40–59 | 87 (20.5) |
| > 60 | 30 (7.1) |
| Specimen | |
| Urine | 93 (21.9) |
| Vaginal smear | 175 (41.4) |
| Urethral smear | 155 (36.6) |
| Isolate | |
| | 286 (67.6) |
| | 34 (8.0) |
| | 13 (3.1) |
| | 24 (5.7) |
| | 12 (2.8) |
| | 37 (8.7) |
| | 5 (1.2) |
| | 1 (0.2) |
| | 11 (2.6) |
Fig. 1Comparison of the resistance of Staphylococcus isolates and all other isolates to the various antimicrobials from selected laboratories in the Buea Health District, Cameroon, from 2012 to 2017
Resistance patterns of the isolated uropathogens to common antimicrobials in the Buea Health District, Cameroon between 2012 and 2016
| Year | Ceftriaxone | Gentamicin | Amoxicillin | Amoxicillin/clavulanic acid | Nitrofurantoin | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||||||||
| 2012 | 4.8 | 1.88 (0.29–11.91) | 0.51 | 2.7 | 0.52 (0.05–5.89) | 0.60 | 21.2 | 6.19 (1.91–20.04) |
| 38.5 | 2.00 (0.59–6.78) | 0.27 | 20.0 | 3.00 (0.74–12.11) | 0.12 |
| 2013 | 8.6 | 9.09 (1.55–3.39) |
| 1.4 | 1.29 (0.18–9.47) | 0.80 | 62.5 | 8.82 (2.73–28.54) |
| 55.6 | 1.14 (0.29–4.60) | 0.85 | 42.9 | 1.45 (0.37–5.68) | 0.59 |
| 2014 | 31.2 | 2.90 (0.46–15.53) | 0.28 | 3.5 | 1.87 (0.25–13.79) | 0.54 | 70.4 | 1.86 (0.28–12.31) | 0.52 | 41.7 | 1.60 (0.19–13.24) | 0.66 | 26.7 | 4.00 (0.20–78.7) | 0.36 |
| 2015 | 11.8 | 4.90 (1.04–23.17) |
| 5.0 | 6.32 (1.38–29.03) |
| 33.3 | 16.10 (3.57–72.68) |
| 50.0 | 2.08 (0.83–5.23) | 0.12 | 50.0 | 1.00 (243–4.11) | 1.00 |
| 2016 | 19.7 | 1 | – | 15.1 | 1 | – | 81.8 | 1 | – | 56.5 | 1 | – | 20.0 | 1 | – |
Bold text indicates p < 0.05
OR odds ratio, R resistance
Resistance trends of the isolated uropathogens to common antimicrobials in the Buea Health District, Cameroon, between 2012 and 2017
| Drug | Correction coefficient | |
|---|---|---|
| Ceftriaxone | 0.658 | 0.198 |
| Gentamicin |
|
|
| Amoxicillin | 0.687 | 0.178 |
| Amoxicillin/clavulanic acid | 0.700 | 0.188 |
| Nitrofurantoin | 0.103 | 0.870 |
| Ciprofloxacin | 0.600 | 0.285 |
| Vancomycin | 0.678 | 0.169 |
| Tetracycline | − 0.100 | 0.873 |
| Cefotaxime | 0.400 | 0.505 |
Bold text indicates p < 0.05
| In Cameroon, lack of bacterial testing, circulation of fake drugs, and irrational use of un-prescribed antimicrobials has led to a progressive rise in antimicrobial resistance. |
| Our findings showed a progressively rising rate of antimicrobial resistance in the uropathogens isolated, with highest rates of resistance to amoxicillin/clavulanic acid while most pathogens, except |
| Uncontrolled and irrational use or prescription of antimicrobials should be avoided so as to maintain low resistance of highly susceptible antimicrobials. |